세계의 마이크로캐리어 시장 : 제품, 용도, 최종 사용자별 예측(2025-2030년)

The Microcarriers Market was valued at USD 2.16 billion in 2023, expected to reach USD 2.37 billion in 2024, and is projected to grow at a CAGR of 9.99%, to USD 4.22 billion by 2030.

Microcarriers are essential tools in the biotechnology and pharmaceutical industries, serving as small beads that provide surface areas for the cultivation of adherent cells in bioreactors. These carriers facilitate the large-scale production of cells by providing a cost-effective and efficient method for mass cell culture. Their necessity lies in bridging the gap between laboratory-scale cell production and industrial-scale manufacturing, crucial for producing vaccines, therapeutic proteins, and regenerative medicines. Applications span across biologics production, cell therapy, and tissue engineering, with end-use scope including pharmaceutical and biopharmaceutical companies, research institutes, and academic laboratories.

The growing need for cell-based vaccines and therapeutic treatments is driving the demand for microcarriers. Advances in cell therapy and regenerative medicine, coupled with increasing investments in R&D, further boost market growth. The potential opportunities lie in the development of microcarriers optimized for specific cell types, enhancing cell harvest efficiency, and adopting biodegradable materials to minimize environmental impact. To capitalize on these opportunities, companies can invest in developing microcarriers with improved surface modification techniques, which enhance cell attachment and growth, and expand their application in 3D cell culture systems.

Despite these promising opportunities, the market faces challenges such as high costs associated with the development and sterilization of microcarriers and complexities in optimizing cell culture processes. Regulatory hurdles in biologics manufacturing also pose a significant limitation. For innovation, focusing on multipurpose microcarriers that allow for expansion of both stem cells and differentiated cells can be a game-changer, catering to a broader range of therapeutic applications.

Market growth is inherently tied to advancements in cell culture technology and increasing biopharmaceutical production demands. As the industry progresses towards more personalized and regenerative medicine solutions, microcarriers offer an essential enabling technology that requires continuous innovation and adaptation to meet the evolving needs of cell-based therapies and biologics manufacturing.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Microcarriers Market

The Microcarriers Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing demand for cell-based therapeutics
  • Government financial support for cell and gene-based research & development
  • Growing preference for single-use microcarrier-based bioreactor system
• Market Restraints
  • Limitation to the cell enumeration due to higher cell density
• Market Opportunities
  • Increasing R&D efforts in microcarries by biopharma companies
  • Potential applications in 3D cultures and rapid usage of the microcarries in mAb production
• Market Challenges
  • Challenges to harvesting cells from macroporous carriers

Porter's Five Forces: A Strategic Tool for Navigating the Microcarriers Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Microcarriers Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Microcarriers Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Microcarriers Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Microcarriers Market

A detailed market share analysis in the Microcarriers Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Microcarriers Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Microcarriers Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Microcarriers Market

A strategic analysis of the Microcarriers Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Microcarriers Market, highlighting leading vendors and their innovative profiles. These include Aber Instruments Ltd., Bangs Laboratories, Inc., Bio-Rad Laboratories, Inc., Carroucell, ChemoMetec A/S, Cole-Parmer Instrument Company, Corning Inc., Cytiva, denovoMATRIX GmbH, Entegris, Inc., Eppendorf AG, Esco Vaccixcell, FUJIFILM Holdings Corporation, Getinge AB, Irvine Scientific, Kuraray Co., Ltd., Lonza Group AG, Matrix F.T., Merck KGaA, Modern Meadow Inc., nanoComposix, Inc., Pall Corporation, Polysciences Inc., PromoCell GmbH, Repligen Corporation, RoosterBio, Inc., Sartorius AG, Sunresin New Materials Co.Ltd., Teijin Limited, and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Microcarriers Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Consumables and Equipment. The Consumables is further studied across Media and Reagents. The Equipment is further studied across Accessories, Bioreactors, Cell Counters, Culture Vessels, and Filtration Systems.
• Based on Application, market is studied across Biologics Manufacturing, Cell Therapy, and Vaccine Manufacturing.
• Based on End User, market is studied across CRO & Research Institutes and Pharmaceutical & Biotechnology Companies.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing demand for cell-based therapeutics
    • 5.1.1.2. Government financial support for cell and gene-based research & development
    • 5.1.1.3. Growing preference for single-use microcarrier-based bioreactor system
  • 5.1.2. Restraints
    • 5.1.2.1. Limitation to the cell enumeration due to higher cell density
  • 5.1.3. Opportunities
    • 5.1.3.1. Increasing R&D efforts in microcarries by biopharma companies
    • 5.1.3.2. Potential applications in 3D cultures and rapid usage of the microcarries in mAb production
  • 5.1.4. Challenges
    • 5.1.4.1. Challenges to harvesting cells from macroporous carriers
• 5.2. Market Segmentation Analysis
  • 5.2.1. Product: Innovations in the microcarrier-based equipment for increasing scalability and production process flexibility
  • 5.2.2. Application: Extensive usage of microcarriers in biomedical applications, with potential applications in tissue engineering and regenerative medicine
  • 5.2.3. End User: Utilization of microcarriers in healthcare institutions in preference to their performance accuracy and scalability
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Microcarriers Market, by Product

• 6.1. Introduction
• 6.2. Consumables
  • 6.2.1. Media
  • 6.2.2. Reagents
• 6.3. Equipment
  • 6.3.1. Accessories
  • 6.3.2. Bioreactors
  • 6.3.3. Cell Counters
  • 6.3.4. Culture Vessels
  • 6.3.5. Filtration Systems

7. Microcarriers Market, by Application

• 7.1. Introduction
• 7.2. Biologics Manufacturing
• 7.3. Cell Therapy
• 7.4. Vaccine Manufacturing

8. Microcarriers Market, by End User

• 8.1. Introduction
• 8.2. CRO & Research Institutes
• 8.3. Pharmaceutical & Biotechnology Companies

9. Americas Microcarriers Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Microcarriers Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Microcarriers Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
  • 12.3.1. Teijin Frontier Introduces Nonwoven Microcarriers for Cell Culture
  • 12.3.2. Australia Boosts Bioprocessing with Government Grants
  • 12.3.3. Cellevate expands the collaboration with the University of Dundee, UK, to optimize the use of the Cellevat3d microcarriers in AAV-based production for cell and gene therapy
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Aber Instruments Ltd.
• 2. Bangs Laboratories, Inc.
• 3. Bio-Rad Laboratories, Inc.
• 4. Carroucell
• 5. ChemoMetec A/S
• 6. Cole-Parmer Instrument Company
• 7. Corning Inc.
• 8. Cytiva
• 9. denovoMATRIX GmbH
• 10. Entegris, Inc.
• 11. Eppendorf AG
• 12. Esco Vaccixcell
• 13. FUJIFILM Holdings Corporation
• 14. Getinge AB
• 15. Irvine Scientific
• 16. Kuraray Co., Ltd.
• 17. Lonza Group AG
• 18. Matrix F.T.
• 19. Merck KGaA
• 20. Modern Meadow Inc.
• 21. nanoComposix, Inc.
• 22. Pall Corporation
• 23. Polysciences Inc.
• 24. PromoCell GmbH
• 25. Repligen Corporation
• 26. RoosterBio, Inc.
• 27. Sartorius AG
• 28. Sunresin New Materials Co.Ltd.
• 29. Teijin Limited
• 30. Thermo Fisher Scientific Inc.